Anthem Inc $ 268.15 0 (0%)
ANTM News and Headlines - Anthem
Shares of drugstore chain CVS Health Corp. (CVS) rose on Wednesday morning on the back of strong fourth-quarter and full-year 2019 earnings results that were boosted by higher sales in its pharmacy benefit management business.
The Woonsocket, Rhode Island-based company posted adjusted earnings of $1.73 per share for the quarter, topping Refinitiv’s estimates of $1.68. Revenue grew 22.9% from the prior-year quarter to $66.9 billion, beating expectations of $63.97 billion. Same-store sales increased 3.2%.
On an unadjusted basis, CVS reported quarterly net income of $1.75 billion, or $1.33 per share, which improved from a loss of $419 million, or
Anthem, Inc. (ANTM)
Like UnitedHealth, Anthem has been affected by the primary debates, but the recent change in expectations of a single-payer healthcare system has boosted the stock price over the last quarter. Future price movements for Anthem may continue to be impacted by ongoing election year debates. Anthem’s membership base stood at nearly 41 million members as of October 2019, an increase of 2.7% over October of last year. Both revenue and earnings increased by double digits during the quarter due to membership growth and premium rate increases. The company has been consistent with returning capital
Winter 2019 Market Commentary
In the fourth quarter, the combination of a US-China trade deal, a resolution of Brexit and sharp declines in interest rates provided strong tailwinds for equities both domestic and international. A record low unemployment rate, declining energy prices and historically low borrowing costs have aided consumer spending and the service sector. Long-term interest rates, as measured by the 30-year Treasury bond, declined from 3.02% at the end of 2018 to 2.39% as of December 31, 2019. Rock bottom interest rates led to a refinancing boom which accounted for 38% of mortgage originations in 2019 (WSJ). Declining
According to GuruFocus insider data, these are the largest CEO buys from the past week.
Anthem Inc. (ANTM) President and CEO Gail Boudreaux bought 7,600 shares on Jan. 30 at a price of $263.70. The price of the stock has increased by 4.85% since then.
With over 40 million members, Anthem is one of the largest managed care organizations in the United States, providing individual, group and government-sponsored health insurance. It operates under the Blue Cross/Blue Shield brand in 14 states.
The company has a market cap of $70.11 billion. Its shares traded
According to GuruFocus Insider Data, these are the largest CEO buys during the past week.
Anthem Inc. (ANTM) President and CEO Gail Boudreaux bought 7,600 shares on Jan. 30 at a price of $263.70. The price of the stock has increased by 0.6% since.
With over 40 million members, Anthem is one of the largest managed-care organizations in the United States. The firm provides individual, group and government-sponsored health insurance. The firm operates under the Blue Cross/Blue Shield brand in 14 states.
The company has a market cap of $67.27 billion. Its
According to the Aggregated Portfolio, a GuruFocus Premium feature, the four broadest-owned stocks within the health care sector are UnitedHealth Group Inc. (UNH), Johnson & Johnson (JNJ), Merck & Co. Inc. (MRK) and Anthem Inc. (ANTM).
Dow finishes first week of December strong as November jobs growth exceeds expectations
The Bureau of Labor Statistics said on Friday that total nonfarm payroll employment increased by 266,000 in November, topping the Dow Jones estimate of 187,000 by approximately 42.24%. Investors cheered on the strong job report, sending the Dow Jones Industrial Average 337.27 points higher to 28,015.06 from Thursday’s
Anthem Inc. (ANTM)
The health insurance industry has been down on talks of Medicare-for-All in the Democratic Primary overriding the otherwise positive results from Anthem. Both Sen. Warren and Sen. Sanders have healthcare proposals that would either eliminate or severely cut down the role of private health insurance providers at an estimated cost in excess of $30 trillion. Health insurance stocks have gone down as the odds that one of these senators is elected goes up. Although it is possible, and starting to become more likely, that one of these senators is nominated as the democratic nominee they would still
The Vanguard Health Care Fund (Trades, Portfolio), which invests at least 80% of its assets in stocks of companies principally related to the health care industry, bought shares of the following stocks in both the second and third quarters.
Anthem Inc. (ANTM)
The fund increased its position by 17.36% in the second quarter and then raised it by 4.17% in the third quarter. The stock has a weight of 2.45% in the portfolio.
The American managed-care organization has a market cap of $68.90 billion. Its revenue of $100.17 billion has grown
Anthem’s (ANTM) stock underperformed during the quarter due to general weakness among health care insurance stocks. We think Anthem is attractively priced at current levels.
From [url=https://www.gurufocus.com/StockBuy.php?GuruName=Yacktman+Asset+Management]Yacktman Asset Management[/url] ([url=https://www.gurufocus.com/StockBuy.php?GuruName=Yacktman+Asset+Management]Trades[/url], [url=https://www.gurufocus.com/holdings.php?GuruName=Yacktman+Asset+Management]Portfolio[/url])'s [url=https://www.gurufocus.com/StockBuy.php?GuruName=Yacktman+Fund]Yacktman Fund[/url] ([url=https://www.gurufocus.com/StockBuy.php?GuruName=Yacktman+Fund]Trades[/url], [url=https://www.gurufocus.com/holdings.php?GuruName=Yacktman+Fund]Portfolio[/url]) third-quarter 2019 shareholder letter.
The AMG [url=https://www.gurufocus.com/StockBuy.php?GuruName=Yacktman+Fund]Yacktman Fund[/url] ([url=https://www.gurufocus.com/StockBuy.php?GuruName=Yacktman+Fund]Trades[/url], [url=https://www.gurufocus.com/holdings.php?GuruName=Yacktman+Fund]Portfolio[/url]) (the Fund) declined slightly in the third quarter, decreasing -0.28% compared to the S&P 500® Index’s1.7% increase and the Russell 1000® Value Index, which rose 1.36%. For the first nine months of 2019 the Fund has lagged market returns, but, looking back over the last year, the Fund has outperformed both of its benchmarks, increasing 6.31% compared to 4.25% for the S&P 500® Index and 4.00% for the Russell 1000® Value Index.
We continued to rebalance the portfolio in the third quarter, reducing successful investments like Procter & Gamble (P&G) and PepsiCo, and building
US-based health insurer Anthem lost value as news of the impeachment process came to the fore. On the assumption that both Trump and Democratic contender Joe Biden will be tarnished by this process, investors began to consider the potential impact of a presidential victory by Elizabeth Warren, who has argued for the abolition of private health insurance.
From the First Eagle Global Value Fund's third-quarter 2019 shareholder letter.
U.S. stocks were in the green on Tuesday, amid strong earnings reported from several banks. The Dow Jones Industrial Average gained 0.89% to 27,024, the S&P 500 index jumped 1.00% to 2,996, and the Nasdaq Composite Index advanced 1.24% to 8,148.
Shares of Johnson & Johnson (JNJ) jumped more than 1.5% on Tuesday, after the company announces third quarter results. The company posted earnings of $2.12 per share, on $20.73 billion on revenues. The company beat earnings estimates by 11 cents and $590 million in revenues.
Consumer worldwide operational sales rose 1.3% driven by Neutrogena beauty products and over-the-counter products
The investor trimmed his Microsoft Corp. (MSFT) stake by 56.3%. The trade had an impact of -3.12% on the portfolio.
The software company has a market cap of $1.06 trillion and an enterprise value of $1 trillion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of 42.84% and return on assets of 14.81% are outperforming 81% of
The fund established a new position in Pfizer Inc. (PFE), buying 22.29 million shares. The trade had an impact of 2.22% on the portfolio.
The pharmaceutical company has a market cap of $212.67 billion and an enterprise value of $246.56 billion.
GuruFocus gives the company a profitability and growth rating of 7 out of 10. The return on equity of 18.97% and return on assets of 7.79% are outperforming 51% of
Shares of health care insurers have suffered lately as investors are spooked by the prospect of Medicare for All, but the threat may be overblown.
Many believe it’s far from a sure thing that a national health insurance plan will be implemented soon, even after the 2020 election.
Although comprehensive Medicare for All legislation has been introduced in both chambers of Congress, the current Democratic leaders — Senator Chuck Schumer of New York and Nancy Pelosi of California, the House speaker — haven’t endorsed it. And the Trump administration wants government to have a smaller role in health care, not
U.S. stocks were higher Friday on a stronger-than-expected reading of the first-quarter gross domestic product. The Dow Jones Industrial Average gained 0.08% to 26,484, the S&P 500 index advanced 0.19% to 2,931 and the Nasdaq Composite Index rose 0.06% to 8,123.
Shares of Intel Corp. (INTC) fell more than 10% on Friday after the company announced first-quarter results. Revenue was flat from the prior-year quarter at $16.1 billion, beating expectations by $70 million. Earnings of 89 cents per share beat estimates by 2 cents.
"Our team is focused on expanding our market opportunity, accelerating our innovation and improving execution while
According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.
Anthem Inc. (ANTM) is held by 24 gurus
The company, which provides network-based managed care plans, has a market cap of $65.05 billion. Its revenue of $92.10 billion has grown 12.50% over a 10-year period.
The stock is trading with a price-earnings ratio of 14.56. The current share price of $252.85 is 20.48% below its 52-week high and 14.95% above its 52-week low. Over the last 10 years, it has returned 485%.
The company’s largest shareholder among the gurus is the Andreas
Diabetes sufferers are having a hard time surviving these days. The cost of insulin in the United States has doubled since 2012, up an astonishing 1,000% since 2000, and there is no consensus as to why this is happening. Without insulin, diabetes patients will die, and many simply cannot afford to keep living. So what is responsible for the price explosion and how can it be stopped?
The finger-pointing rages between insulin manufacturers and pharmacy benefit managers, but the truth may be that neither of them are responsible. Let’s take a look and see why.
We often hear
The Vanguard Health Care Fund (Trades, Portfolio), which offers investors low-cost exposure to domestic and foreign companies involved in various aspects of the health care industry, bought shares of the following stocks in the fourth quarter.
The fund boosted its CVS Health Corp. (CVS) stake by 160.80%, expanding the portfolio by 1.12%.
The company, which operates retail pharmacies, has a market cap of $84.92 billion and an enterprise value of $106.12 billion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. The return on equity of
According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs.
CenterPoint Energy Inc. (CNP) reached the 52-week high of $29.38
CenterPoint Energy Inc. owns and operates a portfolio of energy-related businesses. The company primarily provides transmission and distribution services and has natural gas distribution systems in the U.S. CenterPoint Energy owns a portfolio of energy-related businesses. Its regulated electric utility provides transmission and distribution services to Houston and the surrounding area. The company has natural gas distribution systems in six states, including the cities of Houston and Minneapolis. CenterPoint owns